Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib.

Authors

Christine Saraceni, Lehigh Valley Health NetworkFollow
P. Mark Li MD, PhD, Lehigh Valley Health NetworkFollow
Justin F Gainor
Gary A. Stopyra MD, Lehigh Valley Health NetworkFollow
Eliot L. Friedman MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

7-1-2015

Volume

10

Issue

7

First Page

1116

Last Page

1117

ISSN

1556-1380

Published In/Presented At

Saraceni, C., Li, P. M., Gainor, J. F., Stopyra, G. A., & Friedman, E. L. (2015). Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib. Journal Of Thoracic Oncology: Official Publication Of The International Association For The Study Of Lung Cancer, 10(7), 1116-1117. doi:10.1097/JTO.0000000000000409

Disciplines

Hematology | Medical Sciences | Medicine and Health Sciences

PubMedID

26134230

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Hematology-Medical Oncology Division Fellows and Residents, Department of Pathology and Laboratory Medicine, Pathology Laboratory Medicine Faculty, Department of Surgery, Department of Surgery Faculty

Document Type

Article